Children have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection rates and a substantially lower risk for developing severe coronavirus disease 2019 …

To investigate the immune response and mechanisms associated with severe coronavirus
disease 2019 (COVID-19), we performed single-cell RNA sequencing on nasopharyngeal …

Background and aims Non‐alcoholic fatty liver disease (NAFLD) is becoming increasingly
prevalent and nutrition intervention remains the most important therapeutic approach for …

In coronavirus disease 2019 (COVID-19), hypertension and cardiovascular diseases are
major risk factors for critical disease progression. However, the underlying causes and the …

Liver fibrosis is a critical complication of obesity-induced fatty liver disease. Wnt1 inducible
signaling pathway protein 1 (WISP1/CCN4), a novel adipokine associated with visceral …

The clinical course of COVID-19 is highly variable, however, underlying host factors and
determinants of severe disease are still unknown. Based on single-cell transcriptomes of …

The risk of developing severe COVID‐19 rises dramatically with age. Schoolchildren are
significantly less likely than older people to die from SARS‐CoV‐2 infection, but the molecular …

Rationale: Pharmacological improvement of CFTR function with elexacaftor/tezacaftor/ivacaftor
(ETI) provides unprecedented improvements in lung function and other clinical outcomes …

To cope with novel virus infections to which no prior adaptive immunity exists, the body
strongly relies on the innate immune system. In such cases, including infections with SARS-CoV-2…

In COVID-19, hypertension and cardiovascular diseases have emerged as major risk
factors for critical disease progression. Concurrently, the impact of the main anti-hypertensive …